slotkoers
Andere beurzen
|
Variatie 5 dagen | Verschil t.o.v. 1 jan (%) | ||
12,35 CNY | -18,75% | -15,81% | -45,40% |
Vakgebied
Aantal werknemers: 1 522
Verkoop per activiteit
CNY in miljoen | 2021 | Gewicht | 2022 | Gewicht | Delta |
---|---|---|---|---|---|
Antibiotics
24,1
%
| 447 | 29,6 % | 435 | 24,1 % | -2,72% |
Cardiovascular Drugs
18,3
%
| 266 | 17,6 % | 331 | 18,3 % | +24,34% |
Antiallergic Drugs
14,5
%
| 294 | 19,5 % | 262 | 14,5 % | -10,80% |
Gastrointestinal Drugs
13,1
%
| 155 | 10,3 % | 236 | 13,1 % | +52,06% |
Others
10,0
%
| 150 | 9,9 % | 180 | 10,0 % | +20,48% |
First Aid Medicine
9,1
%
| - | - | 164 | 9,1 % | - |
Non-steroidal Anti-inflammatory Drugs
7,1
%
| 119 | 7,9 % | 129 | 7,1 % | +8,55% |
Dermatological Drugs
3,9
%
| 79 | 5,2 % | 70 | 3,9 % | -11,51% |
Verkoop per regio
CNY in miljoen | 2021 | Gewicht | 2022 | Gewicht | Delta |
---|---|---|---|---|---|
China
83,7
%
| 1 277 | 84,7 % | 1 511 | 83,7 % | +18,30% |
International
16,3
%
| 231 | 15,3 % | 295 | 16,3 % | +27,57% |
Managers
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Min Hua Fan
CEO | Chief Executive Officer | 63 | 14-07-92 |
Tong Ning Luo
DFI | Director of Finance/CFO | 49 | 01-10-04 |
Ji Ping Wang
BRD | Director/Board Member | 52 | 01-07-10 |
Mao Zhou
BRD | Director/Board Member | 54 | 01-10-12 |
Hui Fang Xie
BRD | Director/Board Member | 43 | 01-10-04 |
Shi Jun Wu
IRC | Investor Relations Contact | - | - |
Besturend
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Shu Ge Jiao
BRD | Director/Board Member | 58 | 01-06-15 |
Min Hua Fan
CEO | Chief Executive Officer | 63 | 14-07-92 |
Hui Fang Xie
BRD | Director/Board Member | 43 | 01-10-04 |
Mao Zhou
BRD | Director/Board Member | 54 | 01-10-12 |
Tong Ning Luo
DFI | Director of Finance/CFO | 49 | 01-10-04 |
Ji Ping Wang
BRD | Director/Board Member | 52 | 01-07-10 |
Ya Dong Chen
BRD | Director/Board Member | 54 | 26-11-18 |
De Zhu Fan
BRD | Director/Board Member | 58 | 26-11-18 |
Yu Ding
CHM | Chairman | 43 | 01-12-08 |
Lei Pan
BRD | Director/Board Member | 40 | - |
Aandelenklasse
Stemming | Aantal | Vrij verhandelbaar | Bedrijfseigen aandelen | Drijvend Totaal | |
---|---|---|---|---|---|
Aandeel A | 1 | 455 008 088 | 261 896 449 ( 57,56 %) | 3 232 923 ( 0,7105 %) | 57,56 % |
Participaties
Naam | Aandelen | % | Totale waarde |
---|---|---|---|
4 191 623 | 1.30% | 10 340 650 $ |
Bedrijfsgegevens
Hainan Poly Pharm. Co., Ltd.
Guilinyang Economic Dev Zone Meilan District
571127, Haikou
+
http://www.hnpoly.comSector
Verkoop per activiteit
Verkoop per regio
Herzieningen van WPA
Winst van het jaar - Afwijkingspercentage
Vaira. 1 jan. | Kapi. | |
---|---|---|
-45,40% | 765 mln. | |
+26,08% | 662 mld. | |
+21,85% | 546 mld. | |
-4,77% | 359 mld. | |
+16,97% | 323 mld. | |
+5,69% | 289 mld. | |
+13,68% | 234 mld. | |
+4,58% | 198 mld. | |
-10,55% | 194 mld. | |
+8,08% | 167 mld. |
- Beurs
- Aandelen
- Koers 300630
- Onderneming Hainan Poly Pharm. Co., Ltd